Effect of selected substances with antiglycative and antioxidative properties on erythrocyte deformability in diabetic patients

Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae

Volumn 75, Issue 5, 2002, Pages 239-244

  Beder I ^a   Kittova M ^a   Mataseje A ^a   Carsky J ^a   Orszaghova Z ^a   Babinska K ^a  

^a Bratislava   (Slovakia)

Author keywords

Diabetes mellitus; Erythrocyte elasticity; Membrane active substances

Indexed keywords

AMINOGUANIDINE; GLYCOSYLATED HEMOGLOBIN; GUANIDINE DERIVATIVE; HEMOGLOBIN; INSULIN; PYRIDOXAL; PYRIDOXYLIDEAMINOGUANIDINE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL SEPARATION; CELL VOLUME; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; GLYCATION; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; RETICULOCYTE COUNT;

EID: 0036909992     PISSN: 12113395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bračoková I, Bohuš B, Štimmelová J, Dorko E, Švorc P. Determination of parameter erythrocyte membrane deformability by means of hemolytic action of mercury ions after exercise. Physiol Res 2000; 49: 34P.
2. Turchetti V, Leoncini F, De Matteis C, Trabalzini L, Guerini M, Forconi S. Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra-erythrocytic calcium. Clin Hemorheol Microcirc 1998; 18: 141-149.
3. Bekyarova G, Yankova T. Alpha-tocopherol and reduced glutatione deficiency and decreased deformability of erythroctes after thermal skin injury. Acta Physiol Pharmacol (Bulg) 1998; 23: 55-59.
4. Bekyarova G, Yankova T, Kozarev I. Combined application of alpha-tocopherol and FC-43 perfluorocarbon emulsion supresses early postburn lipid peroxidation and improves deformability of erythrocytes. Acta Chir Plast 1998; 40: 17-21.
5. Hardeman MR, Ince C. Clinical potential of in vitro measured red cell deformability, a myth? Clin Hemorheol Microcirc 1999; 21: 277-284.
6. Linderkamp O, Ruef P, Zilow EP, Hoffmann GF. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin dependent diabetes mellitus. Diabetologia 1999; 42: 865-869.
7. Cicco G, van der Kleij AJ, Manicone A, Vicenti P, Dolce E, Pirelli A. The effect of Losartan on red blood cell deformability and tissue oxygenation in patients with arterial hypertension. Adv Exp Med Biol 1998; 454: 663-666.
8. Cicco G, Pirelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin Hemorheol Microcirc 1999; 21: 169-177.
9. Jakuš V, Hrnčiarová M, Čársky J, Krahulec B, Rietbrock N. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant. activity. Life Sci 1999; 65: 1991-1993.
10. Taguchi T, Sugiura M, Hamada Y, Miwa Y. Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal. Eur J Pharm 1999; 378: 283-289.
11. Hrnčiarová M, Čársky J, Jakuš V, Zlatoš L, Kucharská J, Gvozdjáková A. Inhibition of erythrocyte lipid peroxidation in diabetic rats by aminoguanidine, resorcylidenaminoguanidine and their oxygen and sulfur analogs. Bratisl Lek Listy 1998; 99: 364-367.
12. Brownlee M, Vlasara H, Kooney T, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986; 232: 1629-1632.